Delivery Order SPE2DB20D3104-SPE2DB21FV9L2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4563636625 - Bupropion HCL XL 150 mg tablets. The $10,420.09 firm-fixed-price contract has a completion date of February 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $2,854.28, is for the delivery of Bupropion HCL XL 300 mg tablets over the period ending on January 26, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $25,866.44, is for the delivery of Bupropion HCL XL 150 mg tablets over a 2-year period ending in May 2024. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation mentioned, indicating an open competition. The contract is structured as a Delivery Order under a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Bupropion HCL XL 300 mg tablets. The contract is a Firm Fixed Price Delivery Order valued at $18,004.58, with a completion date of February 29, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $4,176.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,564,502,725 units of Bupropion HCL XL 300 mg tablets, a medication used to treat depression. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $5,768.03 for the supply of 500 units of BUPROPION HCL XL 300 MG TABLET to the agency. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The award is not designated as a set-aside contract and was issued under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $43,909.44 delivery order contract is for the supply of Bupropion HCL XL 150 mg tablets, with a completion date of December 11, 2023. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $13,869.60, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Bupropion HCL XL 150 mg tablets in quantities of 500 tablets per bottle. This is a Firm Fixed Price Delivery Order contract with a completion date of February 8, 2024. The contract was awarded on February 7, 2024 and does not have a set-aside designation, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $29,534.76 firm-fixed-price delivery order is for the supply of Bupropion HCL XL 150 mg tablets, a generic medication used to treat depression. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,407.58 firm fixed-price delivery order is for the provision of 4,563,605,046 units of Bupropion HCL XL 150 mg tablets. The contract has an ultimate completion date of February 9, 2024. Amerisourcebergen Drug Corp is an established pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB21FV9L2Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,236.40 firm fixed-price delivery order is for 4554453792 Bupropion HCL XL 150 mg tablets, with an ultimate completion date of August 18, 2021. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, Cencora, Inc. also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 8/17/21 |